Sloan et al developed a model for predicting 30 day mortality in patients who develop intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction (AMI). This can help identify patients who may benefit from more aggressive management and monitoring. The authors are investigators from the GUSTO-I trial.

To read more or access our algorithms and calculators, please log in or register.